엘라스토그래피 이미징 시장 규모, 점유율, 동향 분석 : 모달리티별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Elastography Imaging Market Growth & Trends:

The global elastography imaging market size is estimated to reach USD 3.47 billion by 2030, expanding at a CAGR of 7.32% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing incidence of breast cancer and chronic liver disorders is expected to significantly drive the market. Additionally, increasing demand for minimally-invasive procedures and ongoing studies to assess the potential applications of elastography are factors expected to contribute toward rapid growth.

Currently elastography has wide applications in assessing breasts, thyroid, prostate, and liver. Increasing number of ongoing studies are expected to increase its applications in diagnosis of various conditions such neurodegenerative disorders and chronic kidney diseases. It has shown promising results for its use in assessment of kidney health during and after transplantation.

North America dominated the market in 2023 and is expected to continue its dominance during the forecast period. The elastography imaging market growth observed in the region is due to the presence of a large number of global players, along with high adoption rate for advanced imaging techniques.

Growing strategic alliances among players for development and distribution of products is expected to propel the market during the forecast period. Moreover, development of new surgical centers in different locations will increase the adoption of advanced imaging systems.

Elastography Imaging Market Report Highlights:

• By modality, the ultrasound segment is predicted to register significant growth during the forecast period owing to advantages such as low price, accessibility, and high degree of measurement for tissue deformation.
• On the basis of end use, the hospital segment is anticipated to hold the largest share in the market during the forecast period due to rising number of ultrasound and MRI-based elastography procedures and growing trends of hospital-based imaging facilities.
• By way of application, the radiology domain is predicted to hold a large share in the market over the forecast period owing to increase in demand in image-guided radiotherapy and radiology ultrasound.
• Asia Pacific is anticipated to witness lucrative growth during the forecast period due to improving healthcare facilities and rising geriatric population who are prone to developing targeted disorders.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Segment Definitions
    • 1.1.1.1. Modality Segment
    • 1.1.1.2. Application Segment
    • 1.1.1.3. End use segment
• 1.2. Regional Scope
• 1.3. Estimates and Forecast Timeline
• 1.4. Objectives
  • 1.4.1. Objective - 1
  • 1.4.2. Objective - 2
• 1.5. Research Methodology
• 1.6. Information Procurement
  • 1.6.1. Purchased Database
  • 1.6.2. GVR's Internal Database
  • 1.6.3. Secondary Sources
  • 1.6.4. Primary Research
• 1.7. Information Or Data Analysis
  • 1.7.1. Data Analysis Models
• 1.8. Market Formulation & Validation
• 1.9. Model Details
  • 1.9.1. Commodity Flow Analysis
• 1.10. List of Primary Sources
• 1.11. List of Abbreviations

Chapter 2. Elastography Imaging Market: Executive Summary

• 2.1. Market Snapshot
• 2.2. Modality and Application Snapshots
• 2.3. End Use Snapshot
• 2.4. Competitive Landscape Snapshot

Chapter 3. Elastography Imaging Market Variables, Trends, & Scope

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Dynamics
• 3.4. Market Drivers Analysis
  • 3.4.1. Growing demand of minimally invasive surgery
  • 3.4.2. Growing incidence of breast cancer and chronic liver diseases
  • 3.4.3. Growing number of product launches
• 3.5. Market Restraint Analysis
  • 3.5.1. High cost of elastography imaging system
• 3.6. Elastography Imaging Market Analysis Tools
  • 3.6.1. Industry Analysis - Porter's
    • 3.6.1.1. Supplier Power
    • 3.6.1.2. Buyer Power
    • 3.6.1.3. Substitution Threat
    • 3.6.1.4. Threat of New Entrant
    • 3.6.1.5. Competitive Rivalry
  • 3.6.2. PESTLE Analysis
    • 3.6.2.1. Political Landscape
    • 3.6.2.2. Technological Landscape
    • 3.6.2.3. Economic Landscape
  • 3.6.3. Pricing Analysis

Chapter 4. Elastography Imaging: Modality Estimates & Trend Analysis

• 4.1. Modality Market Share, 2024 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Elastography Imaging Market By Modality Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for The Following
  • 4.4.1. Ultrasound Elastography
    • 4.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Magnetic Resonance Elastography
    • 4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Elastography Imaging: Application Estimates & Trend Analysis

• 5.1. Application Market Share, 2024 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Elastography Imaging Market By Application Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for The Following
  • 5.4.1. General Imaging
    • 5.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Hepatology
    • 5.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Breast
    • 5.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.4.4. Cardiology
    • 5.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.4.5. Nephrology
    • 5.4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.4.6. Orthopedic and Musculoskeletal
    • 5.4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.4.7. Others
    • 5.4.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Elastography Imaging: End Use Estimates & Trend Analysis

• 6.1. End use Market Share, 2024 & 2030
• 6.2. Segment Dashboard
• 6.3. Global Elastography Imaging Market By End use Area Outlook
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for The Following
  • 6.4.1. Hospital
    • 6.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.4.2. Imaging Centers
    • 6.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Others
    • 6.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Regional Business Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Marker Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.5. North America
  • 7.5.1. U.S.
    • 7.5.1.1. Key Country Dynamics
    • 7.5.1.2. Competitive Scenario
    • 7.5.1.3. Regulatory Framework
    • 7.5.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5.2. Canada
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5.3. Mexico
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Mexico Elastography Imaging Market, 2018 - 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. UK
    • 7.6.1.1. Key Country Dynamics
    • 7.6.1.2. Competitive Scenario
    • 7.6.1.3. Regulatory Framework
    • 7.6.1.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Germany
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6.3. Spain
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6.4. France
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6.5. Italy
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6.6. Denmark
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6.7. Sweden
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6.8. Norway
    • 7.6.8.1. Key Country Dynamics
    • 7.6.8.2. Competitive Scenario
    • 7.6.8.3. Regulatory Framework
    • 7.6.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key Country Dynamics
    • 7.7.1.2. Competitive Scenario
    • 7.7.1.3. Regulatory Framework
    • 7.7.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.7.4. South Korea
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Framework
    • 7.7.4.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.7.5. Thailand
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Framework
    • 7.7.5.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.7.6. Australia
    • 7.7.6.1. Key Country Dynamics
    • 7.7.6.2. Competitive Scenario
    • 7.7.6.3. Regulatory Framework
    • 7.7.6.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key Country Dynamics
    • 7.8.1.2. Competitive Scenario
    • 7.8.1.3. Regulatory Framework
    • 7.8.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.8.2. Argentina
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 7.9. MEA
  • 7.9.1. MEA Elastography Imaging Market, 2018 - 2030 (USD Million)
  • 7.9.2. South Africa
    • 7.9.2.1. Key Country Dynamics
    • 7.9.2.2. Competitive Scenario
    • 7.9.2.3. Regulatory Framework
    • 7.9.2.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.9.3. Saudi Arabia
    • 7.9.3.1. Key Country Dynamics
    • 7.9.3.2. Competitive Scenario
    • 7.9.3.3. Regulatory Framework
    • 7.9.3.4. Saudi Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.9.4. UAE
    • 7.9.4.1. Key Country Dynamics
    • 7.9.4.2. Competitive Scenario
    • 7.9.4.3. Regulatory Framework
    • 7.9.4.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.9.5. Kuwait
    • 7.9.5.1. Key Country Dynamics
    • 7.9.5.2. Competitive Scenario
    • 7.9.5.3. Regulatory Framework
    • 7.9.5.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company /Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. List of Key Distributors and Channel Partners
  • 8.3.2. Key Customers
  • 8.3.3. Key Company Market Share Analysis, 2024
  • 8.3.4. Canon Medical Systems Corporation
    • 8.3.4.1. Overview
    • 8.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.4.3. Product Benchmarking
    • 8.3.4.4. Strategic Initiatives
  • 8.3.5. Esaote SpA
    • 8.3.5.1. Overview
    • 8.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.5.3. Product Benchmarking
    • 8.3.5.4. Strategic Initiatives
  • 8.3.6. FUJIFILM Corporation
    • 8.3.6.1. Overview
    • 8.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.6.3. Product Benchmarking
    • 8.3.6.4. Strategic Initiatives
  • 8.3.7. GE Healthcare
    • 8.3.7.1. Overview
    • 8.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.7.3. Product Benchmarking
    • 8.3.7.4. Strategic Initiatives
  • 8.3.8. Hitachi, Ltd.
    • 8.3.8.1. Overview
    • 8.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.8.3. Product Benchmarking
    • 8.3.8.4. Strategic Initiatives
  • 8.3.9. Koninklijke Philips N.V.
    • 8.3.9.1. Overview
    • 8.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.9.3. Product Benchmarking
    • 8.3.9.4. Strategic Initiatives
  • 8.3.10. Mindray Bio-Medical Electronics Co., Ltd.
    • 8.3.10.1. Overview
    • 8.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.10.3. Product Benchmarking
    • 8.3.10.4. Strategic Initiatives
  • 8.3.11. Samsung Medison Co., Ltd.
    • 8.3.11.1. Overview
    • 8.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.11.3. Product Benchmarking
    • 8.3.11.4. Strategic Initiatives
  • 8.3.12. Siemens
    • 8.3.12.1. Overview
    • 8.3.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.12.3. Product Benchmarking
    • 8.3.12.4. Strategic Initiatives
  • 8.3.13. Toshiba America Medical Systems, Inc.
    • 8.3.13.1. Overview
    • 8.3.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.13.3. Product Benchmarking
    • 8.3.13.4. Strategic Initiatives